Alector (ALEC) Change in Acquisitions & Divestments (2018 - 2026)
Alector (ALEC) reported Change in Acquisitions & Divestments of $112.9 million for Q1 2026, down 7.14% year-over-year from $121.5 million in Q1 2025, and up 131.71% quarter-over-quarter from -$355.9 million in Q4 2025.
Alector (ALEC) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $112.9 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $112.9 million, down 7.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.7 million (down 101.12% YoY), and the FY2025 annual result was $3.0 million, down 99.48% from the prior year.
- Change in Acquisitions & Divestments improved to $112.9 million in Q1 2026 per ALEC's latest filing, from -$355.9 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $571.7 million in Q4 2024 and troughed at -$355.9 million in Q4 2025.
- A 5-year average of $73.0 million and a median of $112.9 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments slumped 417.7% in 2023, then surged 16211.04% in 2024.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $181.7 million in 2022, then sank by 98.07% to $3.5 million in 2023, then surged by 16211.04% to $571.7 million in 2024, then tumbled by 162.25% to -$355.9 million in 2025, then soared by 131.71% to $112.9 million in 2026.
- Business Quant data shows ALEC's Change in Acquisitions & Divestments at $112.9 million in Q1 2026, -$355.9 million in Q4 2025, and $355.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.87 Mn |
| Mar 31, 2026 | 112.87 Mn |
| Dec 31, 2025 | -355.91 Mn |
| Dec 31, 2025 | -355.91 Mn |
| Sep 30, 2025 | 355.91 Mn |
| Sep 30, 2025 | 355.91 Mn |
| Jun 30, 2025 | -118.57 Mn |
| Jun 30, 2025 | -118.57 Mn |
| Mar 31, 2025 | 121.55 Mn |
| Mar 31, 2025 | 121.55 Mn |
| Dec 31, 2024 | 571.70 Mn |
| Dec 31, 2024 | 571.70 Mn |
| Jun 30, 2024 | -183.38 Mn |
| Jun 30, 2024 | -183.38 Mn |
| Mar 31, 2024 | 185.23 Mn |
| Mar 31, 2024 | 185.23 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Jun 30, 2023 | -210.00 Mn |
| Jun 30, 2023 | -210.00 Mn |